Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical Cord-derived MSCs for Severe BPD in Premature Infants
NCT06788470Phase 2Recruiting
- Sponsor
- Children's Hospital, Zhejiang University School of Medicine
- Start
- Aug 2024
- Primary completion
- Aug 2027
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of human umbilical cord mesenchymal stem cells in bronchopulmonary dysplasia (BPD), sponsored by Children's Hospital, Zhejiang University School of Medicine. Primary endpoints: Extubating time after MSC transplantation, Number of times and total duration of re-intubation and 1 more. Started Aug 2024; status: recruiting.
02
Drugs
human umbilical cord mesenchymal stem cells
03
Conditions
bronchopulmonary dysplasia (BPD)
Beyond the preview
Go deeper on NCT06788470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06788470.